Pharma's roller-coaster relationship with RNA therapies
Abstract
After a groundswell of hype and a sceptical backlash, the pharmaceutical industry is learning how to leverage RNA interference in the clinic.
- Publication:
-
Nature
- Pub Date:
- October 2019
- DOI:
- 10.1038/d41586-019-03069-3
- Bibcode:
- 2019Natur.574S...4E